06:44 AM EST, 11/04/2024 (MT Newswires) -- Integra LifeSciences Holdings ( IART ) reported Q3 adjusted earnings Monday of $ 0.41 per diluted share, down from $0.76 a year earlier.

Analysts polled by Capital IQ expected $0.39.

Total revenue for the quarter ended Sept. 30 was $380.8 million, down from $382.4 million a year earlier.

Analysts surveyed by Capital IQ expected $375.8 million.

The company said it expects Q4 adjusted EPS of $0.81 to $0.89. Analysts surveyed by Capital IQ expect $0.87. For Q4, Integra LifeSciences ( IART ) expects revenue of $441 million to $451 million. Analysts polled by Capital IQ expect $448.5 million.